![]() |
Creative Consultants |
|
|
REPRODUCTION TOXICITY Fertility
and Reproduction Studies
Results : Males :
Dose-related body weight gain suppressions of 17 and 25%, and food
consumption suppressions of 7 and 16%, occurred during the 11-week premating
treatment period at 100 and 175 mg/kg, respectively, compared with vehicle
controls. There were no treatment-related effects on testes, epididymides or
accessory organs weights, testicular or epididymal sperm counts, sperm motility,
or sperm morphology during Week 15 of treatment. There were no effects on
copulation or fertility indices, number of days to mating, or female
reproductive parameters (number of implants, live fetuses, or pre- and
postimplantation loss).(23) Females : The mean number of estrous cycles, copulation and fertility indices, number of days to mating, and number of viable litters were comparable between groups. In addition, term sacrifice parameters (number of corpora lutea, implants, live fetuses, pre- and postimplantation loss) were not significantly different between groups.(23)
Results : At 300 mg/kg in rats, 1 treatment-related death occurred
on day 12 of gestation and maternal body weight gain and food consumption were
decreased during treatment (43% and 23%, respectively). In addition, 1 animal at
300 mg/kg had total litter resorption. Increased postimplantation loss (not
statistically significant) and slightly decreased fetal body weight
(statistically significant only in males) were also observed at 300 mg/kg. There
were no significant differences between treated and control groups in the
incidence of fetal malformations or variations. No maternal or developmental
toxicity was observed in rats at 10 or 100 mg/kg.(24)
Results : In rabbits, marked maternal toxicity (7 deaths, body
weight loss during and after treatment, and decreased food consumption) and
abortion occurred at 100 mg/kg. At 50 mg/kg, maternal toxicity (2 deaths and 72%
body weight gain suppression) and abortion also occurred. There were no
treatment-related effects on live litter size or sex ratio. At 50 and 100 mg/kg,
nonstatistically significant increases in postimplantation loss and decreases in
gravid uterine weight were observed, and at 100 mg/kg, decreases in fetal body
weight were observed relative to controls.(24)
Results : Offspring survival at birth and during the neonatal
period at 225 mg/kg was reduced relative to control by up to 45%, and 28% of
litters had no viable offspring by 10 days postpartum. Additional effects on
offspring included reduced body weight during the neonatal and maturation
periods (100, 225 mg/kg), delayed
appearance of pinnae detachment and incisor eruption (225 mg/kg), impaired
rotorod performance (females only; 100, 225 mg/kg), reduced acoustic startle
responding (males only; 20, 100, 225 mg/kg), and transient effects on shuttle
avoidance (females only; 225 mg/kg). No treatment-related effects were observed
on offspring reproduction.(25)
|